Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout (2019)

First Author: Hill-McManus D
Attributed to:  North West HTMR funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1454

PubMed Identifier: 30993686

Publication URI: http://europepmc.org/abstract/MED/30993686

Type: Journal Article/Review

Parent Publication: Clinical Pharmacology & Therapeutics

Issue: 3